Drug Screen Targeted at Plasmodium Liver Stages Identifies a Potent Multistage Antimalarial Drug

Plasmodium parasites undergo a clinically silent and obligatory developmental phase in the host’s liver cells before they are able to infect erythrocytes and cause malaria symptoms. To overcome the scarcity of compounds targeting the liver stage of malaria, we screened a library of 1037 existing dru...

Descripción completa

Detalles Bibliográficos
Autores principales: da Cruz, Filipa P., Martin, Cécilie, Buchholz, Kathrin, Lafuente-Monasterio, Maria J., Rodrigues, Tiago, Sönnichsen, Birte, Moreira, Rui, Gamo, Francisco-Javier, Marti, Matthias, Mota, Maria M., Hannus, Michael, Prudêncio, Miguel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2012
Materias:
Major Articles and Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3308910/
https://www.ncbi.nlm.nih.gov/pubmed/22396598
http://dx.doi.org/10.1093/infdis/jis184

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3308910/
https://www.ncbi.nlm.nih.gov/pubmed/22396598
http://dx.doi.org/10.1093/infdis/jis184

Ejemplares similares